These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26772918)

  • 1. PFTK1 regulates cell proliferation, migration and invasion in epithelial ovarian cancer.
    Zhang W; Liu R; Tang C; Xi Q; Lu S; Chen W; Zhu L; Cheng J; Chen Y; Wang W; Zhong J; Deng Y
    Int J Biol Macromol; 2016 Apr; 85():405-16. PubMed ID: 26772918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
    Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
    J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CAP1 is overexpressed in human epithelial ovarian cancer and promotes cell proliferation.
    Hua M; Yan S; Deng Y; Xi Q; Liu R; Yang S; Liu J; Tang C; Wang Y; Zhong J
    Int J Mol Med; 2015 Apr; 35(4):941-9. PubMed ID: 25652936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PFTK1 Promotes Gastric Cancer Progression by Regulating Proliferation, Migration and Invasion.
    Yang L; Zhu J; Huang H; Yang Q; Cai J; Wang Q; Zhu J; Shao M; Xiao J; Cao J; Gu X; Zhang S; Wang Y
    PLoS One; 2015; 10(10):e0140451. PubMed ID: 26488471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
    Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
    Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of Abelson interactor protein 1 predicts tumor progression and poor outcome in epithelial ovarian cancer.
    Zhang J; Tang L; Chen Y; Duan Z; Xiao L; Li W; Liu X; Shen L
    Hum Pathol; 2015 Sep; 46(9):1331-40. PubMed ID: 26193797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capn4 Enhances Osteopontin Expression through Activation of the Wnt/β-Catenin Pathway to Promote Epithelial Ovarian Carcinoma Metastasis.
    Yang X; Sun J; Xia D; Can X; Liu L; Zhang J; Xu H; Du N; Liu W; Shen F; Zhang Z; Sun Y; Xi X
    Cell Physiol Biochem; 2017; 42(1):185-197. PubMed ID: 28535511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancer.
    Li T; Xue H; Guo Y; Guo K
    Oncol Rep; 2014 Apr; 31(4):1825-31. PubMed ID: 24573179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of protein kinase CK2α correlates with poor patient prognosis in epithelial ovarian cancer.
    Ma Z; Wang X; He J; Xia J; Li Y
    PLoS One; 2017; 12(3):e0174037. PubMed ID: 28355289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Cyclin G1 in cellular proliferation and apoptosis of human epithelial ovarian cancer.
    Jiang L; Liu R; Wang Y; Li C; Xi Q; Zhong J; Liu J; Yang S; Wang J; Huang M; Tang C; Fang Z
    J Mol Histol; 2015 Jun; 46(3):291-302. PubMed ID: 25981880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSMB4 expression associates with epithelial ovarian cancer growth and poor prognosis.
    Liu R; Lu S; Deng Y; Yang S; He S; Cai J; Qiang F; Chen C; Zhang W; Zhao S; Qian L; Mao G; Wang Y
    Arch Gynecol Obstet; 2016 Jun; 293(6):1297-307. PubMed ID: 26439929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of HOXC8 is Associated With Poor Prognosis in Epithelial Ovarian Cancer.
    Lu S; Liu R; Su M; Wei Y; Yang S; He S; Wang X; Qiang F; Chen C; Zhao S; Qian L; Shao M; Mao G
    Reprod Sci; 2016 Jul; 23(7):944-54. PubMed ID: 26763553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of microRNA-100 and its functional roles in human epithelial ovarian cancer.
    Peng DX; Luo M; Qiu LW; He YL; Wang XF
    Oncol Rep; 2012 Apr; 27(4):1238-44. PubMed ID: 22246341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dickkopf-4 is frequently overexpressed in epithelial ovarian carcinoma and promotes tumor invasion.
    Wang S; Wei H; Zhang S
    BMC Cancer; 2017 Jun; 17(1):455. PubMed ID: 28666421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of centrosomal protein 55 is associated with unfavorable prognosis and tumor invasion in epithelial ovarian carcinoma.
    Zhang W; Niu C; He W; Hou T; Sun X; Xu L; Zhang Y
    Tumour Biol; 2016 May; 37(5):6239-54. PubMed ID: 26615423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Knockdown of PFTK1 Expression by RNAi Inhibits the Proliferation and Invasion of Human Non-Small Lung Adenocarcinoma Cells.
    Liu MH; Shi SM; Li K; Chen EQ
    Oncol Res; 2016; 24(3):181-7. PubMed ID: 27458099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High GMFG expression correlates with poor prognosis and promotes cell migration and invasion in epithelial ovarian cancer.
    Zuo P; Ma Y; Huang Y; Ye F; Wang P; Wang X; Zhou C; Lu W; Kong B; Xie X
    Gynecol Oncol; 2014 Mar; 132(3):745-51. PubMed ID: 24486602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitin-specific protease 14 (USP14) regulates cellular proliferation and apoptosis in epithelial ovarian cancer.
    Wang Y; Wang J; Zhong J; Deng Y; Xi Q; He S; Yang S; Jiang L; Huang M; Tang C; Liu R
    Med Oncol; 2015 Jan; 32(1):379. PubMed ID: 25429837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stomatin-like protein 2 is overexpressed in epithelial ovarian cancer and predicts poor patient survival.
    Sun F; Ding W; He JH; Wang XJ; Ma ZB; Li YF
    BMC Cancer; 2015 Oct; 15():746. PubMed ID: 26487491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.
    Wang ZQ; Faddaoui A; Bachvarova M; Plante M; Gregoire J; Renaud MC; Sebastianelli A; Guillemette C; Gobeil S; Macdonald E; Vanderhyden B; Bachvarov D
    Oncotarget; 2015 Oct; 6(31):31522-43. PubMed ID: 26372729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.